NCT00956267View on ClinicalTrials.gov

Letrozole or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome.

NACompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

Letrozole

2.5 mg letrozole oral tablets daily from day 3 of the menses for 5 days up to 6 cycles

PROCEDURE

Laparoscopic ovarian diathermy (LOD)

Three-puncture technique. Each ovary was cauterized at four points, each for 4 seconds at 40 W for a depth of 4 mm with a mixed current, using an monopolar electrosurgical needle.

Trial Locations (1)

35511

Mansoura University Hospitals,OB/GYN department, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT00956267 - Letrozole or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome. | Biotech Hunter | Biotech Hunter